Thomas Bhatt

Thomas Bhatt is a computational biologist specializing in neoantigen prediction and prioritization for cancer immunotherapy applications. His algorithms for predicting MHC binding affinity and T cell recognition have significantly improved neoantigen vaccine design. He has developed integrated pipelines that combine genomic, transcriptomic, and proteomic data to identify high-quality neoantigens. His tools are widely used by academic and industry groups developing personalized cancer immunotherapies.